Outcomes of Traumatic Arterial Injuries in Upper vs. Lower Extremities

April 3, 2022 updated by: Abanoub Emad Mousa Daniel, Assiut University
The purpose of this study is to identify and compare the causes of vascular trauma at the extremities, injury characteristics, types of vascular surgical interventions, and the outcomes of traumatic vascular injuries between the upper and lower extremities.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

  1. Primary patient assessment Patients will be clinically assessed on presentation, and resuscitation protocols will be initiated if signs of hypovolemic shock are present according to Advanced Trauma Life Support guidelines.
  2. History and physical examination are the most important components of the diagnostic protocol The presence of hard signs of arterial injury

    • Absent or diminished pulses
    • Active haemorrhage
    • Large, expanding, or pulsatile hematoma
    • Bruit or thrill
    • Distal ischemia is considered an indication for surgery, and no further specific investigative measures will be taken.

    Soft signs of vascular trauma should be noted as well including

    • Small, stable hematoma
    • Unexplained hypotension
    • History of haemorrhage that is no longer present
    • Proximity of injury to major vessels
  3. Investigations including:

    • The use of a hand-held Doppler examination as a diagnostic aid
    • Duplex US and CTA for imaging.
    • Lab investigations: Complete blood picture, Coagulation profile and Kidney function tests.

Options of intervention:

All vascular trauma patients will be admitted for operative management and follow up. The specific surgical intervention will be determined by the vascular surgeon according to type, site, and extent of the injury, ranging from ligation of the injured vessel to vascular graft interposition.

An injury to a peripheral artery that does not result in complete transection can be repaired depending on luminal diameter with an interrupted or continuous suturing technique. A complete transection of a peripheral artery is first managed with minimal debridement back to healthy intima at both ends then an end-to-end anastomosis or with an interposition graft of autogenous vein or prosthetics arterial graft.

Study Type

Observational

Enrollment (Anticipated)

65

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients fulfilling the previous criteria who are operated at Assiut University Hospital - Department of Vascular and Endovascular Surgery.

Description

Inclusion Criteria:

  • All peripheral arterial injuries of one or more of the extremities.

Exclusion Criteria:

  • Vascular injuries limited to the venous system only.
  • Vascular injuries limited to thoracic, abdominal, or neck vessels.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Upper extremity arterial trauma
Vascular traumatic injuries of the arterial system of the upper limbs.
Lower extremity arterial trauma
Vascular traumatic injuries of the arterial system of the lower limbs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of distal pulse or signals by doppler ultrasound
Time Frame: Intraoperative
Presence of distal pulse or signals by doppler ultrasound which indicates technical success of the surgery and patency of the affected artery
Intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Type of the injury in the upper extremities compared with the lower extremities
Time Frame: Preoperative
blunt or penetrating injury by history and clinical examination
Preoperative
Presentation of the injury in the upper extremities compared with the lower extremities
Time Frame: Preoperative
Bleeding or ischemia by clinical examination.
Preoperative
Presence of injury related complications in the upper extremities compared with the lower extremities
Time Frame: Preoperative
Presence of complications(or not) like compartment syndrome, hematoma or/and associated nerve deficit by clinical examination.
Preoperative
Presence of postoperative complications in the upper extremities compared with the lower extremities
Time Frame: Postoperative for 10 days

Presence of complications(or not) like thrombosis of the repaired vessel, pseudoaneurysm formation or/and deep vein thrombosis by clinical examination and Duplex ultrasound evaluation.

Presence of complications(or not) like surgical site infection or/and wound dehiscence by clinical examination and culture and sensitivity.

Postoperative for 10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mohamed A Mubarak, Assiut University
  • Study Director: Ashraf G Taha, Assiut University
  • Study Director: Osman M Ahmed, Assiut University
  • Principal Investigator: Abanoub E Mousa, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2022

Primary Completion (Anticipated)

June 1, 2024

Study Completion (Anticipated)

June 1, 2024

Study Registration Dates

First Submitted

February 16, 2022

First Submitted That Met QC Criteria

April 3, 2022

First Posted (Actual)

April 5, 2022

Study Record Updates

Last Update Posted (Actual)

April 5, 2022

Last Update Submitted That Met QC Criteria

April 3, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Vascular Trauma

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vascular Trauma

3
Subscribe